MiMedx Group, Inc.
MDXG
$4.36
-$0.05-1.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.84% | 15.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.84% | 15.33% | |||
| Cost of Revenue | 1.79% | 0.20% | |||
| Gross Profit | 4.25% | 18.87% | |||
| SG&A Expenses | 5.90% | 7.56% | |||
| Depreciation & Amortization | 15.18% | 12.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.99% | 6.15% | |||
| Operating Income | -5.02% | 79.39% | |||
| Income Before Tax | -4.61% | 75.67% | |||
| Income Tax Expenses | 8.24% | 80.02% | |||
| Earnings from Continuing Operations | -9.30% | 74.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.30% | 74.13% | |||
| EBIT | -5.02% | 79.39% | |||
| EBITDA | -11.58% | 77.13% | |||
| EPS Basic | -9.28% | 73.73% | |||
| Normalized Basic EPS | -4.66% | 75.45% | |||
| EPS Diluted | -9.18% | 83.33% | |||
| Normalized Diluted EPS | -4.93% | 75.37% | |||
| Average Basic Shares Outstanding | 0.04% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.32% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||